ARCHIVES

“Harm-Reduction” Products No Proven, IOM Report Says.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Three Experimental Beamlines To Be Built For Research.

May 17, 2002

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

October 6, 1995

In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online

February 5, 1999

Chemo Can Harm Liver, Affect Surgical Outcomes

May 26, 2006

Two More Treatment Programs Moved To DCT; Rauscher Ponders Fate of Cooperative Groups

April 18, 1975

MRI Contract: AACI Group Still Seething

August 8, 1986